Exposure to natalizumab during pregnancy and lactation is safe - Yes

Mult Scler. 2020 Jul;26(8):887-889. doi: 10.1177/1352458520915814. Epub 2020 Jun 8.

Authors

Doriana Landi¹, Girolama Alessandra Marfia²

Affiliations

¹ Department of Systems Medicine, Tor Vergata University, Rome, Italy/Multiple Sclerosis Clinical and Research Unit, Fondazione Policlinico Tor Vergata, Rome, Italy.
² Department of Systems Medicine, Tor Vergata University, Rome, Italy/Multiple Sclerosis Clinical and Research Unit, Fondazione Policlinico Tor Vergata, Rome, Italy/Unit of Neurology, IRCCS Istituto Neurologico Mediterraneo NEUROMED, Pozzilli, Italy.

PMID: 32508253
DOI: 10.1177/1352458520915814

No abstract available

MeSH terms

Adult
Breast Feeding*
Female
Humans
Immunologic Factors / adverse effects*
Infant
Infant, Newborn
Multiple Sclerosis / drug therapy*
Natalizumab / adverse effects*
Postpartum Period / drug effects*
Pregnancy
Prenatal Exposure Delayed Effects / chemically induced*

Substances

Immunologic Factors
Natalizumab